Patents by Inventor Fabien Gautier

Fabien Gautier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mcl-1 modulating compounds for cancer treatment
    Patent number: 10307410
    Abstract: The invention relates to compounds of formula (I), and to their therapeutic use in the treatment of cancer: Wherein Y1, Y2, Ar1, Ar2, R1, R2, i, j, k, l are as defined in claim 1.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: June 4, 2019
    Assignees: CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE, UNIVERSITE DE CAEN BASSE-NORMANDIE, INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU
    Inventors: Laurent Poulain, Anne-Sophie Voisin-Chiret, Jana Sopkova-de Oliveira Santos, Ronan Bureau, Grégory Burzicki, Marcella De Giorgi, Serge Perato, Jade Fogha, Sylvain Rault, Philippe Juin, Fabien Gautier
  • MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT
    Publication number: 20170071921
    Abstract: The invention relates to compounds of formula (I), and to their therapeutic use in the treatment of cancer: Wherein Y1, Y2, Ar1, Ar2, R1, R2, i, j, k, l are as defined in claim 1.
    Type: Application
    Filed: March 3, 2015
    Publication date: March 16, 2017
    Applicants: CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE, UNIVERSITE DE CAEN BASSE-NORMANDIE, INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU
    Inventors: Laurent POULAIN, Anne-Sophie VOISIN-CHIRET, Jana SOPKOVA-DE OLIVEIRA SANTOS, Ronan BUREAU, Grégory BURZICKI, Marcella DE GIORGI, Serge PERATO, Jade FOGHA, Sylvain RAULT, Philippe JUIN, Fabien GAUTIER
  • TRUNCATED BARD1 PROTEIN, AND ITS DIAGNOSTIC AND THERAPEUTIC USES
    Publication number: 20100016228
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid encoding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumors.
    Type: Application
    Filed: June 23, 2009
    Publication date: January 21, 2010
    Applicant: Ayanda Biosystems SA
    Inventors: FABIEN GAUTIER, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger
  • Truncated BARD1 protein, and its diagnostic and therapeutic uses
    Patent number: 7566764
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.
    Type: Grant
    Filed: September 3, 2001
    Date of Patent: July 28, 2009
    Assignee: Ayanda Biosystems SA
    Inventors: Fabien Gautier, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger
  • Truncated bard1 protein, and its diagnostic and therapeutic uses
    Publication number: 20040234959
    Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.
    Type: Application
    Filed: May 22, 2003
    Publication date: November 25, 2004
    Inventors: Fabien Gautier, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger